Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03WDY
|
||||
Former ID |
DNC007414
|
||||
Drug Name |
N-(1,3,4-thiadiazol-2-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528805] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H7N3OS
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C(=O)NC2=NN=CS2
|
||||
InChI |
1S/C9H7N3OS/c13-8(7-4-2-1-3-5-7)11-9-12-10-6-14-9/h1-6H,(H,11,12,13)
|
||||
InChIKey |
RWOUBULBQYRRNL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [528805] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.